| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25,000 | 12 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000117911022003000-symonds-jonathan-2022-05-12 | Rubius Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Director | 13 May 2022, 16:22 |
| /report/000117911021005317-symonds-jonathan-2021-05-12 | Rubius Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 20:35 |